Hjem › Tripelnegativ brystkreft › Indiana › Indianapolis
Kliniske studier for Tripelnegativ brystkreft i Indianapolis, IN
9 studier for Tripelnegativ brystkreft søker deltakere på steder i og rundt Indianapolis (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
RekruttererFase 1
- IU Simon Cancer Center, Indianapolis
A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)
RekruttererFase 3
- Franciscan Health ( Site 0077), Indianapolis
Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)
RekruttererFase 3
- Franciscan Health Indianapolis, Indianapolis
Toci +/- SOC Chemo for Metastatic Triple Negative and ER-positive, HER2-negative Breast Cancers
RekruttererFase 2
- Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Indianapolis
- Sidney and Lois Eskenazi Hospital, Indianapolis
A Study of LY4175408 in Participants With Advanced Cancer
RekruttererFase 1
- Community Health Network, Indianapolis
Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan
RekruttererFase 1
- Community Health Network, Inc. /ID# 243011, Indianapolis
A Study of Tetrathiomolybdate (TM) Plus Capecitabine
RekruttererFase 1/2
- Indiana University Simon Cancer Center, Indianapolis
NearWave Optical Molecular Monitoring
Rekrutterer
- Indiana University Simon Comprehensive Cancer Center, Indianapolis
A Phase I/II Study of VLS-1488 in Subjects With Advanced Cancer
RekruttererFase 1/2
- Community Health Network, Indianapolis
Tripelnegativ brystkreft-studier i andre byer
- Houston, TX42 studier
- New York City, NY31 studier
- Nashville, TN28 studier
- Los Angeles, CA27 studier
- Boston, MA26 studier
- San Antonio, TX23 studier
- St. Louis, MO21 studier
- Arlington, VA20 studier
- Atlanta, GA20 studier
- Dallas, TX18 studier
- Chicago, IL16 studier
- Columbus, OH16 studier
Andre studier i Indianapolis
- Ikke-småcellet lungekreft32 studier
- Kreft (alle typer)24 studier
- Hjertesvikt23 studier
- Fedme20 studier
- Brystkreft20 studier
- Metastatisk kreft19 studier
- Kolorektal kreft18 studier
- Eggstokkreft17 studier
- Kardiovaskulær sykdom17 studier
- Lungekreft16 studier
- Type 1-diabetes14 studier
- Endometriekreft14 studier
Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.